Psilocybin Therapy Cuts Depression by Over 70% in COVID Healthcare Workers

Dec 5, 2024, 04:07 PM

A study published by the American Medical Association has found that psilocybin therapy, derived from magic mushrooms, led to a significant and sustained reduction in symptoms of depression among frontline healthcare workers, including doctors and nurses, who served during the COVID-19 pandemic. The therapy reduced depression scores by over 70%, compared to a 30% reduction observed with a placebo. Participants experienced an average drop in depression scores, underscoring the potential of psilocybin as a therapeutic option for mental health challenges faced by healthcare professionals.